Article
Second‐trimester Down syndrome maternal serum marker screening: a prospective study of 11 040 twin pregnancies
11 Nov 2008
Abstract excerpt
OBJECTIVE: To analyze the value of Down syndrome (DS) second-trimester maternal serum screening in large series of twin pregnancies. METHODS: Prospective study of second-trimester maternal serum markers [alpha fetoprotein (AFP) and free beta-human chorionic gonadotrophin (beta-hCG)] in 11,040 twin pregnancies, 27 of which were trisomy 21-affected. Comparison with 64,815 singleton pregnancies, of which 86 were...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
